Prolonged QT dispersion in the infants of diabetic mothers

Derya Arslan1, Osman Guvenc, Derya Cimen

  • 1Department of Pediatric Cardiology, Selcuk University Medical Faculty, 42075, Konya, Turkey, deryaamine78@hotmail.com.

Pediatric Cardiology
|April 18, 2014
PubMed

Insights

Newborns of diabetic mothers with septal hypertrophy show increased QT and QTc dispersion, indicating a higher risk for arrhythmias. Early cardiac screening is crucial for these infants.

Area of Science:

  • Cardiology
  • Neonatology
  • Pediatrics

Background:

  • Maternal diabetes can lead to myocardial hypertrophy and cardiac dysfunction in newborns.
  • Left ventricular hypertrophy (LVH) in these infants may impact cardiac electrical activity, specifically QT intervals.

Purpose of the Study:

  • To investigate whether left ventricular hypertrophy affects QT and QTc dispersion in infants born to diabetic mothers.
  • To assess the relationship between septal hypertrophy and QT variables in neonates.

Main Methods:

  • Prospective cross-sectional study involving 47 neonates of diabetic mothers and 30 healthy controls.
  • Electrocardiography (ECG) and echocardiography were performed.
  • Newborns of diabetic mothers were categorized into groups based on septal thickness (hypertrophy vs. no hypertrophy).

Main Results:

  • Infants with septal hypertrophy (n=16) exhibited significantly longer QT and QTc dispersion intervals compared to those without hypertrophy and controls (p < 0.001).
  • A positive correlation was found between interventricular septal thickness at end diastole (IVSTd) and QT dispersion (r = 0.514, p = 0.042).
  • Left ventricular end-systolic diameter was smaller in the septal hypertrophy group.

Conclusions:

  • Elevated QT and QTc dispersion in neonates of diabetic mothers with LVH may signify an increased risk for developing cardiac arrhythmias.
  • Systematic cardiac screening is recommended for these high-risk infants.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
35